Can a smartphone app keep you on track after rehab?

NCT ID NCT07597031

First seen May 21, 2026 · Last updated Jun 23, 2026 · Updated 6 times

Summary

This study tests a digital lifestyle platform designed to support patients after they leave inpatient rehabilitation. It includes people recovering from COPD, heart attacks, fractures, or minor strokes. The goal is to see if the platform is easy to use, acceptable, and helps patients maintain healthy habits over six months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Center for Rehabilitation & Sports Medicine, Berner Reha Zentrum

    RECRUITING

    Schwendi, Heiligenschwendi, 3625, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • University Hospital Inselspital

    RECRUITING

    Bern, Canton of Bern, 3010, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Digital Lifestyle Platform

What this could lead to

If successful, this could show that a digital tool helps people stick to healthy habits after rehabilitation, potentially improving long-term health outcomes.

What could go wrong

This is an early feasibility study with no control group for health outcomes, so it may not prove the platform actually improves health. Engagement may be low, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

acute coronary syndrome chronic obstructive pulmonary disease stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.